RELENZA, an influenza neuraminidase inhibitor, is indicated for: Treatment of influenza in patients 7 years of age and older who have been symptomatic for no more than 2 days. (1.1) Prophylaxis of influenza in patients 5 years of age and older. (1…
RELENZA, an influenza neuraminidase inhibitor (NAI), is indicated for: Treatment of influenza in patients aged 7 years and older who have been symptomatic for no more than 2 days. (1.1)…
BRUKINSA is indicated for the treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy. This indication is approved under accelerated…
Zavara is indicated for dietary management of patients with unique nutritional needs requiring increased folate levels. Vitamin D deficiency or are in need of Vitamin D supplementation and other nutritional supplementation. CLINICAL PHARMACOLOGY…
PRIALT (ziconotide intrathecal infusion) is indicated for the management of severe chronic pain in patients for whom intrathecal (IT) therapy is warranted, and who are intolerant of or refractory to other treatment, such as systemic analgesics,…
This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.
Privacy Policy | Copyright © 2020. All Rights Reserved.